Literature DB >> 21726885

[Toxic leucoencephalopathy after use of sniffed heroin, an unrecognized form of beneficial evolution].

L Havé1, A Drouet, J-L Lamboley, F Cotton, G St-Pierre, L Quesnel, L Guilloton, D Felten.   

Abstract

INTRODUCTION: Serious leukoencephalopathy can be related to heroin injection or inhalation. OBSERVATION: We report the first case of leukoencephalopathy observed three weeks after a 46-year-old man sniffed heroin. The clinical presentation included cognitive and behaviour disorders, pyramidal irritation and slight gait instability. Blood and cerebrospinal fluid analyse were normal. Brain magnetic resonance imaging showed diffuse, symmetrical supratentorial white matter lesions producing high intense signals on FLAIR and b1000-weighted sequences. Proton spectroscopy revealed an increased rate of cholin, in favour of active demyelinated lesions. Brain biopsy showed intramyelinic oedema with reactive gliosis. After two and a half years, moderate attentional fluctuations and difficulties in initiating activities persisted. Repeated MRI showed a reduction of the leukoencephalopathy.
CONCLUSION: Heroin could be a cause more common than thought of leukoencephalopathy. The clinical and radiological expression and prognosis could be related to the mode of consummation (inhalation, intravenous injection, sniffing). This parameter may modulate severity and localization of brain lesions. More systematic use of MRI for patients with psychiatric symptoms after heroin intoxications could lead to a better evaluation of heroin-related neurotoxicity and potentially improve prevention.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726885     DOI: 10.1016/j.neurol.2011.01.022

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  1 in total

1.  Leukoencephalopathy due to inhalational and trans-conjunctival heroin abuse: First case report from Pakistan.

Authors:  Mohammad Suleman Bajwa; Hassan Nawaz; Muhammad Aemaz Ur Rehman; Sadaf Iftikhar; Abu Hurera
Journal:  Ann Med Surg (Lond)       Date:  2022-02-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.